The Vice President hosted a roundtable in the White House to discuss cannabis policy in the country.
In a March 15th, 2024, roundtable at the White House, Vice President Kamala Harris discussed cannabis policy and its impacts in the United States (1,2). Also included in the discussion were rapper Fat Joe, Kentucky Governor Andy Beshear, White House Director of Public Engagement Steve Benjamin, plus several people who had received pardons for cannabis convictions (1,2). Cannabis policy has also been mentioned this month by President Joe Biden.
Part of the roundtable was then held in private, though Vice President Harris made a few public comments (2). “Nobody should have to go to jail for simple marijuana possession, and what we need to do is recognize that far too many people have been sent to jail for simple marijuana possession,” stated Vice President Harris (1). “And the impact is such that, in particular, Black Americans and Latinos are four times more likely—four times more likely—to be arrested for marijuana possession. I believe that the promise of America includes equal justice under the law, and for too many, our criminal justice system has failed to live up to that core principle. And I say that with full knowledge of how this system has worked including my experience as a prosecutor,” (1).
Two weeks ago, President Joe Biden addressed cannabis in his State of the Union speech, mentioning the federal pardons he has granted and the reexamination of cannabis classification at the federal level (3). Action toward this, he explained, has involved “…directing my Cabinet to review the federal classification of marijuana, and expunging thousands of convictions for mere possession, because no one should be jailed for using or possessing marijuana!” (4).
In 2022 Biden had requested Department of Health and Human Services (HHS) to review the status of cannabis as a Schedule I substance (5). The HHS completed their review in 2023 and recently released an unredacted version of their recommendation to classify cannabis as a Schedule III substance, passing the final decision over to the Drug Enforcement Administration (DEA) and Department of Justice (6,7). Vice President Harris noted this development as well (2). “Marijuana is considered as dangerous as heroin and more dangerous than fentanyl, which is absurd,” she stated in the roundtable (2). “Not to mention patently unfair. So I’m sure DEA is working as quickly as possible and will continue to do so and we look forward to the product of their work,” (2).
Additionally, Biden issued an executive order in 2022 pardoning certain cannabis convictions and encouraging governors to issue pardons for cannabis possession in their states (8). That year, Governor Beshear invited people in Kentucky with cannabis convictions to apply for a pardon (2). Earlier this month, Massachusetts Governor Maura Healey declared her intent to pardon cannabis possession convictions in the state (8). If approved by the Governor’s Council, that pardon could affect tens of thousands in Massachusetts (8).
References
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Khan
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.
Ep 24, Part I: Data Transparency in Cannabis Testing with Yasha Khan
November 21st 2024Evan Friedmann interviews Yasha Khan, co-founder of MCR Labs, about his journey into the cannabis industry and his efforts to promote transparency and integrity in laboratory practices. Yasha discusses the origins of MCR Labs, which began in Massachusetts to meet the needs of the soon-to-be legal medical cannabis market. He explains the challenges faced, including result manipulation by labs and the impact on public health. Yasha's Freedom of Information Act (FOIA) project aimed to gather testing data from 37 states, revealed significant discrepancies in potency and mold results. Despite some states' reluctance to share data, Yasha has made much of this data public, leading to collaborative research and publications on various aspects of cannabis testing.